Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay

Journal of Immunological Methods

Volumn 372, Issue 1-2, 2011, Pages 187-195

  Dons'koi, Boris V ^a   Chernyshov, Viktor P ^a   Osypchuk, Darina V ^a  

^a Institute of Pediatrics   (Ukraine)

Author keywords

CD69 expression; Flow cytometry; K562; NK cytotoxicity

Indexed keywords

CD69 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ARTICLE; CELL STRAIN K 562; CYTOTOXICITY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL DEGRANULATION; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DICARBOXYLIC ACIDS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; K562 CELLS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; PYRIDINES; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 80052443942     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.07.016     Document Type: Article

References (29)

1. Aktas E., Kucuksezer U.C., Bilgic S., Erten G., Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 2009, 254(2):149-154.
2. Athié-Morales V., O'Connor G.M., Gardiner C.M. Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide. J. Immunol. 2008, 180(6):4082-4089.
3. Bachy M., Bonnin-Rivalland A., Tilliet V., Trannoy E. Betagalactosidase release as an alternative to chromium release in cytotoxicT-cell assays. J. Immunol. Methods 1999, 230(1-2):37-46.
4. Blomberg K., Ulfstedt A.C. Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J. Immunol. Methods 1993, 160:27-34.
5. Brunner K.T., Mauel J., Cerottini J.C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968, 14:181-196.
6. Chernyshov V.P., Sudoma I.O., Dons'koi B.V., Kostyuchyk A.A., Masliy Y.V. Elevated NK cell cytotoxicity, CD158a expression in NK cells and activated T lymphocytes in peripheral blood of women with IVF failures. Am. J. Reprod. Immunol. 2010, 64(1):58-67. (PubMed: 20236262).
7. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 2006, 24:257-286.
8. Dons'koi BV, Chernyshov VP, Osypchuk DV. Imunophenotypic characteristic of two functional different NK cell's subpopulations of peripheral human blood. Fiziol Zh. 2011; 57(1) ahead of print [PubMed - in process].
9. Giavedoni L.D., Velasquillo M.C., Parodi L.M., Hubbard G.B., Hodara V.L. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J. Virol. 2000, 74(4):1648-1657.
10. Hussain R.F., Nouri A.M., Oliver R.T. A new approach for measurement of cytotoxicity using colorimetric assay. J. Immunol. Methods 1993, 160:89-96.
11. Iizuka K., Chaplin D.D., Wang Y., Wu Q., Pegg L.E., Yokoyama W.M., Fu Y.X. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(11):6336-6340.
12. Iwao M., Ochi C., Kurane I., Muraoka S. A non-radioisotopic human natural killer cell assay using rhodamine-123 fluorescent dye as labeling probe. Immunol. Invest. 1998, 27(1-2):31-45.
13. Kolber M.A., Quinones R.R., Gress R.E., Henkart P.A. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF). J. Immunol. Methods 1988, 108:255-264.
14. Korbel D.S., Newman K.C., Almeida C.R., Davis D.M., Rily E.M. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 2005, 175:7466-7473.
15. Korzeniewski C., Callewaert D.M. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 1983, 64:313-320.
16. Lanier L.L. Natural killer cell receptor signaling. Curr. Opin. Immunol. 2003, 15:308.
17. Le Bouteiller P. El Costa H, Aguerre-Girr M, Tabiasco J [Immunity of pregnancy: novel concepts]. Bull. Acad. Natl. Med. 2009, 193(5):1029-1041. (May).
18. Naranbhai V., Bartman P., Ndlovu D., Ramkalawon P., Ndung'u T., Wilson D., Altfeld M., Carr W.H. Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function. J. Immunol. Methods 2011, (Epub ahead of print] PMID: 21255578).
19. Nociari M.M., Shalev A., Benias P., Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 2011, 366(1-2):28-35.
20. North J., Bakhsh I., Marden C., Pittman H., Addison E., Navarrete C., Anderson R., Lowdell M.W. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J. Immunol. 2007, 178(1):85-94.
21. Ohmori H., Ikeda H., Tanigawa T., Hikida M. Enzyme release assay of human NK cell activity using beta-galactosidase-expressing K562 target cell line. J. Immunol. Methods 1993, 164:131-135.
22. Riley J.K., Yokoyama W.M. NK cell tolerance and the maternal-fetal interface. Am. J. Reprod. Immunol. 2008, 59(5):371-387.
23. Szekeres J., Pacsa A.S., Pejtsik B. Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells. J. Immunol. Methods 1981, 40:151-154.
24. Wang X.M., Terasaki P.I., Rankin G.W., Chia D., Zhong H.P., Hardy S. A new microcellular cytotoxicity test based on calcein AM release. Hum. Immunol. 1993, 37(4):264-270.
25. Whiteside T.L., Herberman R.B. Role of human natural killer cells in health and disease. Clin. Diagn. Lab. Immunol. 1994, 1:125-133.
26. Whiteside T.L., Herberman R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 1995, 7(5):704-710.
27. Whiteside T.L., Bryant J., Day R., Herberman R.B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 1990, 4:102-114.
28. Yamada H., Kato E.H., Kobashi G., Ebina Y., Shimada S., Morikawa M., Sakuragi N., Fujimoto S. High NK cell activity in Early Pregnancy correlates with subsequent abortion with normal chromosomes in women with recurrent abortion. Am. J. Reprod. Immunol. 2001, 46(2):132-136.
29. Ziegler S.F., Ramsdell F., Hjerrild K.A., Armitage R.J., Grabstein K.H., Hennen K.B., Farrah T., Fanslow W.C., Shevach E.M., Alderson M.R. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 1993, 23(7):1643-1648.